American actor Peter Michael Falk has an estimated net worth of $14 million. Best known as the rumpled television detective, Lieutenant Columbo, character actor Peter Falk has also enjoyed a successful film career, often in association with the groundbreaking independent filmmaker John Cassavetes.

Born September 16, 1927, in New York City, Falk lost an eye at the age of three, resulting in the odd, squinting gaze which later became his trademark. He initially pursued a career in public administration, serving as an efficiency expert with the Connecticut Budget Bureau, but in the early '50s, boredom with his work sparked an interest in acting. By 1955, Falk had turned professional, and an appearance in a New York production of The Iceman Cometh earned him much attention. He soon graduated to Broadway and in 1958 made his feature debut in the Nicholas Ray/ Budd Schulberg drama Wind Across the Everglades.

A diminutive, stocky, and unkempt presence, Falk's early screen roles often portrayed him as a blue-collar type or as a thug; it was as the latter in 1960's Murder Inc. that he earned a Best Supporting Actor Oscar nomination, a major career boost. He was nominated in the same category the following year as well, this time as a sarcastic bodyguard in Frank Capra's Pocketful of Miracles. In 1962, Falk won an Emmy for his work in the television film The Price of Tomatoes, a presentation of the Dick Powell Theater series.

In 1968, Falk first assumed the role of Columbo, the disheveled police lieutenant whose seemingly slow and inept investigative manner masked a steel-trap mind; debuting in the TV movie Prescription: Murder, the character was an immediate hit, and after a second telefilm, Ransom for a Dead Man, a regular Columbo series premiered as part of the revolving NBC Mystery Movie anthology in the fall of 1971, running for seven years and earning Falk a second Emmy in the process.

Falk died at his Beverly Hills home on June 23, 2011. According to his daughter, Catherine Falk, the actor had been suffering from dementia and Alzheimer's disease.

Earnings & Financial Data